Thousand Oaks, CA, United States of America

Mike Osborn

This inventor holds 1 USPTO granted patent. Top assignee: Teneobio, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mike Osborn. Retrieved from https://idiyas.com/inventor/mike-osborn-vjx99eiz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mike Osborn: Innovator in Transgenic Technology

Introduction

Mike Osborn is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of transgenic non-human animals. His work focuses on producing modified heavy chain-only antibodies, which have important applications in medical research and therapeutic development.

Latest Patents

Mike Osborn holds a patent for "Transgenic Non-Human Animals Producing Modified Heavy Chain-Only Antibodies." This innovative patent highlights his expertise in genetic engineering and its potential to revolutionize antibody production.

Career Highlights

Osborn is currently employed at Teneobio, Inc., a company that specializes in the development of next-generation antibody therapeutics. His role at Teneobio allows him to further explore and implement his groundbreaking ideas in the field of biotechnology.

Collaborations

Throughout his career, Mike has collaborated with talented professionals, including Shelley Force Aldred and Wim Van Schooten. These partnerships have contributed to the advancement of his research and the successful development of innovative solutions in biotechnology.

Conclusion

Mike Osborn's contributions to the field of biotechnology, particularly through his patent on transgenic non-human animals, demonstrate his commitment to innovation and research. His work at Teneobio, Inc. and collaborations with other experts further enhance the impact of his inventions in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…